Merck announced that the company’s proposed treatment Keytruda for non-small cell lung cancer delivered positive results from a Phase III trial.
In a summary of some recent studies on Covid-19, an arthritis drug cuts the death risk in high-risk patients and heart medications might help prevent Covid-19 blood clots.
